SCOR arbitration award hits Q2 results, shares steady on Euronext

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-26, 09:19.

SCOR (FR0010411983) acknowledged an arbitration tribunal award related to retrocession treaties with Covéa that will trim its second-quarter 2026 net results by about EUR 50 million, while its solvency and liquidity remain unaffected according to the company’s latest press release. The reinsurer’s shares trade on Euronext Paris, putting the decision firmly in the spotlight for European insurance investors. SCOR press release on the arbitration award

Arbitration award and financial impact

The arbitration tribunal issued its award on June 25, 2026 in proceedings that began in 2022, focusing on the enforcement of retrocession treaties entered into between SCOR and Covéa in June 2021. These treaties cover the transfer to Covéa of 30 percent of the Life & Health portfolio held by SCOR’s Irish entities as of December 31, 2020, a sizeable block in the group’s life reinsurance book. Company release detailing the retrocession treaties

The tribunal confirmed the validity of the retrocession treaties but judged it equitable to grant compensation to Covéa, awarding USD 488.3 million in total. According to SCOR, existing provisions will absorb most of the charge, leaving an estimated impact of around EUR 50 million on net results in the second quarter of 2026. Management emphasizes that the hit will not negatively affect the group’s solvency ratio or liquidity position, key balance sheet metrics closely watched by regulators and investors. MarketWatch report on the Covéa compensation

Reinsurer positioning and sector peers

SCOR describes itself as remaining fully focused on executing the final year of its "Forward 2026" strategic plan, which centers on balance sheet resilience and disciplined underwriting in a competitive reinsurance market. The group operates alongside European peers such as Munich Re and Swiss Re, all of which rely on strong solvency ratios to support business growth in property, casualty, and life reinsurance. SCOR statement on Forward 2026 priorities

For investors comparing sector exposure, SCOR’s confirmation that solvency and liquidity will not be impaired by the arbitration outcome is notable. Reinsurers typically face volatile claims experience and regulatory capital demands, so a contained financial impact from legal disputes provides more clarity when assessing risk-adjusted returns relative to listed peers in the European insurance and reinsurance space. MarketWatch sector context on SCOR and Covéa

The business behind the stock

SCOR generates revenue primarily by providing reinsurance solutions to insurers worldwide, spanning Life & Health and Property & Casualty segments. In Life & Health, the group reinsures mortality, longevity, and health risks, including portfolios such as the Irish life block partly retroceded to Covéa under the contested treaties. In Property & Casualty, SCOR offers coverage for natural catastrophes, specialty lines, and large industrial risks, aiming for diversified underwriting with disciplined risk selection.

Where the shares trade today

The SCOR shares (FR0010411983) trade on Euronext Paris at EUR 27.50 as of 2026-06-26, 09:10.

This article is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. All data are based on sources believed to be reliable but may be subject to change. Investors should conduct their own research or consult a qualified financial advisor before making investment decisions.